Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home
Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide History

Buserelin
Acetate

The first GnRH agonist that taught doctors how to turn off hormone signals to fight cancer and help couples have babies

Buserelin is a man-made copy of a natural hormone that controls sex hormones in your body. It was one of the first drugs in its class, developed by Hoechst in the 1980s. Doctors use it to treat prostate cancer, endometriosis, and to help with IVF by controlling when eggs are released. It works by first giving a big signal to your pituitary gland, then turning off the hormone response completely.

Scroll to Discover

Quick Facts

Buserelin at a Glance

Approved and widely used

1982

Discovery Year

When this peptide was first identified

Peptide

Type

Compound classification

Approved and widely used

Status

Current regulatory status

Research compound

Primary Use

Main area of investigation

Injection

Administration

How this peptide is typically given

Peptide chain

Size

Molecular structure type

The Visionaries

Pioneers Who Dared
to Challenge the Impossible

Hoechst AG (now Sanofi), Frankfurt, Germany

Hoechst AG

Developer and manufacturer

Created buserelin as HOE-766 in the early 1980s

""

Hoechst AG Research Division, Frankfurt, Germany

Jürg Stucki

Research scientist

Key researcher in GnRH agonist development at Hoechst

""

Sanofi-Aventis (now Sanofi), Paris, France

Sanofi-Aventis

Current manufacturer

Now produces Suprefact worldwide after Hoechst merger

""

Hoechst AG Endocrinology Division, Germany

Roger Sandow

Pharmacology researcher

Published comprehensive review of buserelin's effects in 1990

""

The Journey

A Story of
Persistence & Triumph

The Discovery

Chapter 1

In the 1970s, doctors faced a tough choice.

Key Moment

In the 1970s, doctors faced a tough choice.

In the 1970s, doctors faced a tough choice. Men with prostate cancer needed their testosterone shut down. Women with endometriosis suffered from painful tissue growing in the wrong places, fed by estrogen. The only answers were surgery, radiation, or strong medicines with awful side effects. Scientists asked: could we use the body's own hormone system against these diseases? The answer was hidden in the pituitary gland.

The Breakthrough

Chapter 2

Researchers discovered that GnRH is the master control hormone.

Key Moment

Researchers discovered that GnRH is the master control hormone.

Researchers discovered that GnRH is the master control hormone. It's a tiny string of amino acids that tells your pituitary gland to release two other hormones: LH and FSH. These hormones then tell your ovaries and testes to make sex hormones. Hoechst scientists realized they could make an artificial version of GnRH that would be super-potent. When you used it over and over, the body's sensors would get tired and shut down the whole system.

The Trials

Chapter 3

Hoechst called their discovery HOE-766, later named buserelin.

Key Moment

Hoechst called their discovery HOE-766, later named buserelin.

Hoechst called their discovery HOE-766, later named buserelin. They tested it in cancer patients first. The results were surprising and powerful. Men with prostate cancer who received buserelin had the same hormone shutdown as men who had their testicles surgically removed. Women with endometriosis finally got relief. By 1982, the drug was approved in Germany. By the late 1980s, doctors all over Europe were using it.

The Crisis

Chapter 4

Then came an unexpected discovery.

Key Moment

Then came an unexpected discovery.

Then came an unexpected discovery. Doctors realized that buserelin could help couples trying to have babies through IVF. By shutting down natural hormone release at just the right time, they could control exactly when eggs grew and were released. This meant women could take hormone shots that made many eggs ready at once, instead of just one per month. Buserelin became a key part of IVF protocols worldwide.

The Legacy

Chapter 5

Today, buserelin remains important for cancer treatment, endometriosis, and fertility help.

Key Moment

It proved that the body's own hormone system could be turned into a powerful medicine.

Today, buserelin remains important for cancer treatment, endometriosis, and fertility help. Scientists learned from buserelin's success and created even better drugs. But buserelin showed them the way. It proved that the body's own hormone system could be turned into a powerful medicine. Now sold as Suprefact across Europe and Asia, it helps thousands of patients every year find relief from serious diseases and achieve their dream of having children.

Years of Progress

Timeline of
Breakthroughs

1977

GnRH hormone structure fully understood by scientists

GnRH hormone structure fully understood by scientists

1979

Hoechst begins development of buserelin as HOE-766

Hoechst begins development of buserelin as HOE-766

1982

Buserelin approved in Germany as Suprefact

Buserelin approved in Germany as Suprefact

1983

First clinical studies show success in prostate cancer patients

First clinical studies show success in prostate cancer patients

1985

Approval in UK and other European countries

Approval in UK and other European countries

1987

Doctors discover usefulness in endometriosis treatment

Doctors discover usefulness in endometriosis treatment

1988

IVF programs begin using buserelin for cycle control

IVF programs begin using buserelin for cycle control

1990

Comprehensive research review published in medical journals

Comprehensive research review published in medical journals

1995

Approval in Japan and other Asian countries

Approval in Japan and other Asian countries

2000

Buserelin nasal spray and injection forms both widely available

Buserelin nasal spray and injection forms both widely available

2005

Over 20 years of safety data compiled from millions of patients

Over 20 years of safety data compiled from millions of patients

2015

Still one of the most used GnRH agonists worldwide

Still one of the most used GnRH agonists worldwide

2020

Continues as first-line treatment for multiple conditions

Continues as first-line treatment for multiple conditions

2023

Remains approved and used across Europe and Asia

Remains approved and used across Europe and Asia

2025

Buserelin teaches new generations of doctors about hormone control

Buserelin teaches new generations of doctors about hormone control

The Science

Understanding
the Mechanism

Buserelin works through a clever trick that takes advantage of how your body learns. Your pituitary gland has sensors that listen for the hormone GnRH. When it hears the signal, it releases two other hormones called LH and FSH. These hormones tell your reproductive organs to make sex hormones. Buserelin is a fake GnRH that your pituitary cannot ignore. At first, it makes the pituitary work overtime. But after a few days, the pituitary gets tired. Its sensors stop responding. The release of LH and FSH drops to almost zero. Sex hormone production crashes. This is called desensitization. It's temporary. When you stop taking buserelin, your pituitary wakes back up.

Molecular Structure

Buserelin is a nine-amino-acid peptide (a short chain of amino acids)

Chemical Name

1239.4 grams per mole

Molecular Weight

Buserelin has changes at two positions that make it ten times stronger and longer-lasting than natural GnRH

How It's Different From GnRH

C60H86N16O13 (contains carbon, hydrogen, nitrogen, and oxygen atoms)

Chemical Formula

Global Impact

Transforming Lives
Across the World

1982

Year buserelin was first

Year buserelin was first approved in Germany

40+ years

Safe clinical use in

Safe clinical use in millions of patients worldwide

3 main uses

Cancer treatment, endometriosis relief

Cancer treatment, endometriosis relief, and fertility help

80-90%

Effectiveness rate in suppressing

Effectiveness rate in suppressing sex hormones when used correctly

Real Stories, Real Lives

Elena

""

David

""

The Future of Buserelin

Research Stage

Combination therapy development - scientists are testing buserelin combined with other drugs to work even better against cancer while causing fewer side effects

Research Stage

New delivery methods - researchers are creating long-acting depot formulations that last months instead of days, making treatment easier for patients

Research Stage

Personalized treatment - doctors are learning to predict which patients will respond best to buserelin before treatment starts, using genetic testing

Research Stage

Extended use studies - ongoing research into long-term safety to help doctors decide the best treatment lengths for different conditions

Be Inspired

The story of Buserelin is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Buserelin Chronicles

Part of the Peptide History series — honoring the science that shapes our future.

© 2026 Peptide History. Educational content for research purposes.

This content is for educational purposes only and should not be considered medical advice.